Navigation Links
MRI May Not Add Value to Routine Breast Cancer Care

Repeat procedure rates are unchanged when scans are used, study finds

THURSDAY, Feb. 11 (HealthDay News) -- Adding expensive MRI scans to diagnose breast cancer won't budge rates of repeat operations or the need for further mastectomy procedures, a new British study suggests.

The COMICE study, published in the Feb. 12 issue of The Lancet, randomly assigned 1,623 women,18 years or older, who had primary breast cancer to have either an MRI or no further scans. This took place after the women underwent triple assessment analysis and were scheduled for tumor-removal surgery.

About half the women were put in each group.

The researchers then followed up to see how many of the women had to undergo a repeat operation or further mastectomy within six months because the entire tumor had not been removed.

The additional MRI scans did not boost the re-operation rate, which was about 19 percent in both groups.

"In the analysis, we identified no difference in health-related quality of life between groups 12 months after initial surgery," wrote the researchers, led by Lindsay Turnbull of the Hull Royal Infirmary.

Adding MRI to the mix may have increased expenses, the research team noted. "In terms of total costs, results suggested a difference between the two trial groups, with the MRI group costing more than the no-MRI group, although the difference was not statistically significant," they said.

"In view of the similar clinical and health related quality-of-life outcomes of patients in both groups, we conclude that the addition of MRI to the conventional triple assessment might result in extra use of resources at the initial surgery period, with few or no benefits to saving resources or health outcomes, and the additional burden on patients to attend extra hospital visits," they wrote.

However, in an accompanying commentary, Dr. Elizabeth A. Morris, of Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College in New York City, cautioned that it may be too early to dispense with preoperative breast MRI. "Importantly, COMICE has shown that preoperative breast MRI might not be for all women and that routine breast MRI in the evaluation of early breast cancer, as managed by those participating in this study, does not decrease reoperation rates," she wrote.

More information:

The U.S. National Cancer Institute has more about breast cancer.

-- Randy Dotinga

SOURCE: The Lancet, news release, Feb. 11, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hard Green Truths - Keynotes Suggest New Value Propositions for River Park Leaders
2. Symptoms have little value for early detection of ovarian cancer
3. Percon Delivers Maximum Value in New Industrial Vehicle Computer Products
4. Morrisey Associates Partners With Total Living Choices (TLC) to Provide Software Value-Add to Customers
5. QHR Hospital Clients Fort Madison Community Hospital, Monroe County Hospital Named to “Best in Value” Top 100 List
6. QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value
7. The UK's Biggest Card Retailer Takes Choice and Value Personally
8. University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources
9. Prescient Medical, Inc. CEO Patricia Scheller to Speak at The Value of Innovation in Health Care, a Galen Institute Conference
10. BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors Informational and Educational Use
11. PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology: